<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 15. Summary of Drug Interactions With Lamotrigine 
			</caption>
<tfoot>
<tr>
<td align="justify" colspan="3">
<sup>a</sup> From adjunctive clinical trials and volunteer trials.<br/>
<sup>b </sup>Net effects were estimated by comparing the mean clearance values obtained in adjunctive clinical trials and volunteer trials.<br/>
<sup>c  </sup>The effect of other hormonal contraceptive preparations or hormone replacement therapy on the pharmacokinetics of lamotrigine has not been systematically evaluated in clinical trials, although the effect may be similar to that seen with the ethinylestradiol/levonorgestrel combinations.<br/>
<sup>d  </sup>Modest decrease in levonorgestrel.<br/>
<sup>e </sup> Slight decrease, not expected to be clinically meaningful.<br/>
<sup>f</sup> Compared to historical controls.<br/>
<sup>g  </sup>Not administered, but an active metabolite of carbamazepine.<br/>
<sup>h   </sup>Not administered, but an active metabolite of oxcarbazepine.<br/>
<sup>i </sup> Not administered, but an active metabolite of risperidone.<br/>
<sup>j</sup> Slight increase, not expected to be clinically meaningful.<br/>↔ = No significant effect.<br/>? = Conflicting data.<br/>
</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td align="center" stylecode="Lrule Rrule" valign="top">
<content stylecode="bold">Drug</content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<content stylecode="bold">Drug Plasma</content>
<br/>
<content stylecode="bold">Concentration With</content>
<br/>
<content stylecode="bold">Adjunctive Lamotrigine<sup>a</sup>
</content>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">
<content stylecode="bold">Lamotrigine Plasma</content>
<br/>
<content stylecode="bold">Concentration With</content>
<br/>
<content stylecode="bold">Adjunctive Drugs<sup>b</sup>
</content>
<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top"> Oral contraceptives (e.g., ethinylestradiol/levonorgestrel)<sup>c</sup>
<br/> Aripiprazole<br/> Atazanavir/ritonavir<br/> Bupropion<br/> Carbamazepine<br/> Carbamazepine epoxide<sup>g </sup>
<br/> Felbamate<br/> Gabapentin<br/> Levetiracetam<br/> Lithium<br/> Lopinavir/ritonavir<br/> Olanzapine<br/> Oxcarbazepine<br/> 10-monohydroxy oxcarbazepine metabolite<sup>h</sup>
<br/> Phenobarbital/primidone<br/> Phenytoin <br/> Pregabalin<br/> Rifampin<br/> Risperidone<br/> 9-hydroxyrisperidone<sup>i</sup>
<br/> Topiramate<br/> Valproate<br/> Valproate + phenytoin and/or carbamazepine<br/> Zonisamide<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">↔<sup>d</sup>
<br/>Not assessed<br/>↔<sup>f</sup>
<br/>Not assessed<br/>↔<br/>?<br/>Not assessed<br/>Not assessed<br/>↔<br/>↔<br/>↔<sup>e</sup>
<br/>↔<br/>↔<br/>↔<br/>↔<br/>↔<br/>↔<br/>Not assessed<br/>↔<br/>↔<br/>↔<sup>j</sup>
<br/>↓<br/>Not assessed<br/>Not assessed<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">↓<br/>↔<sup>e</sup>
<br/>↓<br/>↔<br/>↓<br/> <br/>↔<br/>↔<br/>↔<br/>Not assessed<br/>↓<br/>↔<sup>e</sup>
<br/>↔<br/> <br/>↓<br/>↓<br/>↔<br/>↓<br/>Not assessed<br/> <br/>↔<br/>↑<br/>↔<br/>↔<br/>
</td>
</tr>
</tbody>
</table>